| Trial ID: | L6687 |
| Source ID: | NCT03361878
|
| Associated Drug: |
Metformin Hydrochloride
|
| Title: |
Pharmacokinetics of Metformin Intolerance
|
| Acronym: |
POMI
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2|Metformin Adverse Reaction
|
| Interventions: |
DRUG: Metformin Hydrochloride
|
| Outcome Measures: |
Primary: Metformin AUC, Area under the metformin concentration-time curve, 24 hours | Secondary: Lactate, Change in lactate concentration (incremental AUC), 24 hours
|
| Sponsor/Collaborators: |
Sponsor: NHS Tayside | Collaborators: University of Southern Denmark|University of Dundee|Helmholtz Zentrum München
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
20
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2014-05-04
|
| Completion Date: |
2016-05-05
|
| Results First Posted: |
|
| Last Update Posted: |
2017-12-05
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT03361878
|
